The future of an iconic Orange County medtech entrepreneur – who was once compared to Steve Jobs – is at stake this week.
Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), today issued an open letter to shareholders ...
Masimo CEO Joe Kiano later expressed concern that Apple may have been trying to steal the company’s blood oxygen sensor ...
Apple was also forced to disable the feature on the Series 9 and Ultra 2 last year. Apple has been actively defending against ...
Masimo filed a meritless lawsuit against Politan in California federal court seeking to block our nominations. Over the past month, we have been working to clear this final obstacle and ...
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...
This week in Other Barks & Bites: the Patent Trial and Appeal Board (PTAB) upholds an Apple patent in its dispute with Masimo ...
Masimo is urging stockholders to vote “FOR ... of confidential witnesses in a plaintiff’s securities class action lawsuit against the Company. We have sworn affidavits stating how Quentin ...
Apple is set to announce a new Apple Watch lineup during the 'It's Glowtime' event on Sept 9; here's what you should look out ...
But rivaling smartwatches are better than ever, and with the Masimo lawsuit looming, all eyes are on Apple to see how the new watch does once we get our hands on it. Dan Bracaglia covers fitness ...
Politan owns 9% of Masimo – an approximately $600 million investment that makes us one of the Company’s largest shareholders. For more than two years, we have been working to bring genuine ...
Kiani, who has led the firm for 35 years, says he'll quit if he loses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback